Jan-hendrik Riedel
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Targeting Monocyte Derived CCL17 Attenuates Murine Crescentic Glomerulonephritis by Affecting Renal CCR4+ Regulatory T-Cell Recruitment.
Journal: American journal of nephrology
Published: July 26, 2023
CD4+ T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12.
Journal: Science translational medicine
Published: March 15, 2023
Tissue-specific therapy in immune-mediated kidney diseases: new ARGuments for targeting the IL-23/IL-17 axis.
Journal: The Journal of clinical investigation
Published: June 15, 2021
IL-17 Receptor C Signaling Controls CD4+ TH17 Immune Responses and Tissue Injury in Immune-Mediated Kidney Diseases.
Journal: Journal of the American Society of Nephrology : JASN
Published: April 21, 2021
T helper cell trafficking in autoimmune kidney diseases.
Journal: Cell and tissue research
Published: September 01, 2020
Pathogen-induced tissue-resident memory TH17 (TRM17) cells amplify autoimmune kidney disease.
Journal: Science immunology
Published: December 02, 2019
IL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation.
IL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation.
Journal: Journal of the American Society of Nephrology : JASN
Published: September 01, 2017
T helper type 17 cells in immune-mediated glomerular disease.
Journal: Nature reviews. Nephrology
Published: August 07, 2017
Last Updated: 09/26/2026